Tech Note

Microfluidic alginate sponge activates and transduces T cells

The Lenti‑X T‑Cell Transduction Sponge (T‑cell sponge) is a modified version of our Lenti‑X Transduction Sponge that is optimized specifically for human T cells. The T-cell sponge expedites and streamlines T‑cell lentiviral transduction for research applications, including CAR T‑cell therapy (Agarwalla et al. 2022).

Benefits of the T‑cell sponge supported by the data below:

  • Expedited CAR T‑cell development by combining transduction and activation into one step
  • Reduction of CAR T-cell production time by days
  • Consistent activation across a range of multiplicity of infection (MOI) values
  • Increased or comparable transduction efficiency and cell viability compared to other transduction methods
  • Effective scaling (from 2 x 106–10 x 106 cells)
  • Minimal phenotypic and transcriptomic impact to the resulting cells
  • Reduction in the amount of virus required
  • Omission of T‑cell isolation by using PBMCs directly as T‑cell source in the T-cell sponge

Applications

  • Lentiviral transduction for:
    • T‑cell engineering
    • Gene editing
    • Gene and protein expression
    • Therapeutic model generation
    • Whole-genome screening
    • CAR T‑cell therapy research using lentivirus for gene modification
  • Virus-like particles (VLPs) transduction

Introduction  

Results  

Conclusions  

References